A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: Mitochondrial agents, N-acetylcysteine, and placebo
Version 3 2024-06-18, 12:56
Version 2 2024-06-05, 10:53
Version 1 2019-01-25, 00:00
journal contribution
posted on 2024-06-18, 12:56 authored by Michael BerkMichael Berk, Alyna TurnerAlyna Turner, GS Malhi, C Ng, SM Cotton, Seetal DoddSeetal Dodd, Y Samuni, M Tanious, C McAulay, N Dowling, J Sarris, L Owen, A Waterdrinker, D Smith, Olivia DeanOlivia DeanA randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: Mitochondrial agents, N-acetylcysteine, and placebo
History
Related Materials
- 1.
Location
EnglandOpen access
- Yes
Language
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2019, The Author(s)Journal
BMC MedicineVolume
17Article number
ARTN 18Pagination
1 - 11ISSN
1741-7015eISSN
1741-7015Issue
1Publisher
BMCUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineMitochondriaBipolar disorderDepressionNutraceuticalAdjunctiveOxidative stressDOUBLE-BLINDDISORDERSYMPTOMS110999 Neurosciences not elsewhere classified920410 Mental HealthInstitute for Innovation in Mental and Physical Health and Clinical TranslationFaculty of HealthSchool of Medicine3209 Neurosciences3202 Clinical sciences420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC